unexpected benefits of tirzepatide Mounjaro vs Compounded Tirzepatide: Safety, Cost, and Key Differences Tirzepatide: A Breakthrough Approach to

Originally approved for type 2 diabetes, tirzepatide is now recognized for its effectiveness in supporting weight loss and overall wellness

If the pharmacy compounded your vial on January 1st and assigned a 60-day BUD, you have until March 2nd regardless of when you received it or opened it

Every minute your vial spends outside the refrigerator counts toward that 21-day limit

Avoid platforms offering medication without a prescription or at suspiciously low prices

More than half of participants achieved at least 20% body weight loss

Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management in adults with obesity or overweight with weight-related comorbidities (marketed as Zepbound)